STOCK TITAN

Dillard's, Inc. (DDS) Financials

DDS
FY2025 annual
Revenue $6.6B -0.4% YoY
Net Income $570.2M -3.9% YoY
EPS (Diluted) $36.42 -1.1% YoY
Free Cash Flow $623.6M +2.3% YoY
Market Cap $10.4B as of Oct 17, 2026
Price / Sales 1.6x on $6.6B revenue, FY2025
Price / Earnings 18.2x on $570.2M net income, FY2025
Price / Book 4.9x on $2.1B equity, Q3 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2027, ended Aug 1, 2026 Reported Currency USD FYE January

Newest figures come from the 10-Q for Q3 FY2027, filed Sep 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DDS SEC filings page.

Dillard's, Inc. (DDS) reported $6.6B in revenue for fiscal year 2025, down 0.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DDS FY2025

Dillard's turns sales into cash, but four years of margin compression have reduced earnings faster than revenue.

From FY2022 through FY2025, net margin weakened while free-cash-flow margin held near 10.0%, so declining reported profitability has not produced an equally sharp deterioration in cash conversion.

The pressure is concentrated in profitability rather than scale: revenue was essentially flat in the latest year, yet net income slipped from $593M to $570M as gross margin barely moved. That combination points to costs below gross profit, rather than a collapse in merchandise economics, doing more of the damage.

Cash generation remains more durable than earnings: FY2025 free cash flow was $624M against $570M of net income, so cash generation exceeded accounting profit rather than merely tracking it. Capital expenditures were only $94M, indicating that the current cash profile reflects relatively modest reinvestment, while debt-to-equity remained about 1.0x.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating Dillard's, Inc.'s peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial
5/7

Dillard's, Inc. passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.26x

For every $1 of reported earnings, Dillard's, Inc. generates $1.26 in operating cash flow ($717.0M OCF vs $570.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.5B
YoY-0.4%
QoQ-3.7%
5Y CAGR-1.1%
10Y CAGR+0.4%

Dillard's, Inc. generated $1.5B in revenue in Q3 2027. This represents a decrease of 0.4% from the same quarter a year earlier. Against the prior quarter it is down 3.7%.

Net Income
$97.7M
YoY+34.1%
QoQ-61.0%
5Y CAGR+7.8%
10Y CAGR+7.9%

Dillard's, Inc. reported $97.7M in net income in Q3 2027. This represents an increase of 34.1% from the same quarter a year earlier. Against the prior quarter it is down 61.0%.

EPS (Diluted)
$6.25
YoY+34.1%
QoQ-61.0%

Dillard's, Inc. earned $6.25 per diluted share (EPS) in Q3 2027. This represents an increase of 34.1% from the same quarter a year earlier. Against the prior quarter it is down 61.0%.

EBITDA

Not reported for Q3 2027.

Cash & Balance Sheet

Free Cash Flow
-$59.5M
YoY-198.9%
QoQ-117.1%

Dillard's, Inc. recorded an outflow of $59.5M in free cash flow in Q3 2027, representing a cash shortfall after capex. This represents a decrease of 198.9% from the same quarter a year earlier. Against the prior quarter it is down 117.1%.

Cash & Debt
$763.1M
YoY-24.6%
QoQ-34.1%
5Y CAGR+16.2%
10Y CAGR+22.5%

Dillard's, Inc. held $763.1M in cash as of Q3 2027; long-term debt is not reported for that period.

Dividends Per Share
$0.30
YoY+20.0%
QoQ0.0%
5Y CAGR+14.9%
10Y CAGR+15.7%

Dillard's, Inc. paid $0.30 per share in dividends in Q3 2027. This represents an increase of 20.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
Diluted avg 16M

Dillard's, Inc. had a weighted average of 16M diluted shares in Q3 2027; the shares outstanding count is not reported for that period.

Margins & Returns

Gross Margin
39.1%
YoY+3.0pp
QoQ-4.8pp
5Y change+8.9pp
10Y change+3.7pp

Dillard's, Inc.'s gross margin was 39.1% in Q3 2027, indicating the percentage of revenue retained after direct costs. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.8 percentage points.

Net Margin
6.4%
YoY+1.6pp
QoQ-9.4pp
5Y change+2.2pp
10Y change+3.3pp

Dillard's, Inc.'s net profit margin was 6.4% in Q3 2027, showing the share of revenue converted to profit. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.4 percentage points.

Return on Equity
4.6%
YoY+0.8pp
QoQ-7.8pp
5Y change0.0pp
10Y change+2.1pp

Dillard's, Inc.'s ROE was 4.6% in Q3 2027, measuring profit generated per dollar of shareholder equity. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 7.8 percentage points.

Operating Margin

Not reported for Q3 2027.

Capital Allocation

Capital Expenditures
$22.3M
YoY-16.5%
QoQ+29.4%
5Y CAGR+21.7%
10Y CAGR-8.6%

Dillard's, Inc. invested $22.3M in capex in Q3 2027, funding long-term assets and infrastructure. This represents a decrease of 16.5% from the same quarter a year earlier. Against the prior quarter it is up 29.4%.

R&D Spending

Not reported for Q3 2027.

Share Buybacks

Not reported for Q3 2027.

DDS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DDS quarterly income statement
MetricQ3'2710-QQ2'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-KQ4'2510-KQ3'2510-Q
Revenue$1.5B-0.4%$1.6B+2.7%$1.5B+2.7%$1.5B+1.4%$1.5B-1.6%$2.1B-5.6%$1.5B$1.5B+0.7%
Cost of Revenue$909.3M-5.2%$870.4M+1.5%$831.6M+1.5%$959.3M+3.1%$857.7M0.0%$1.3B-4.9%$819.3M$930.3M+11.5%
Gross Profit$598.2M+7.9%$698.1M+4.0%$637.1M+4.8%$554.5M-0.9%$671.2M-2.9%$724.6M-7.0%$607.7M$559.6M-12.8%
SG&A Expenses$443.6M+2.2%$444.0M+5.3%$440.4M+5.1%$434.2M+0.1%$421.7M-1.2%$457.0M+0.1%$418.9M$433.7M+2.8%
Interest Expense$10.0M-0.8%$10.5M+1.5%$10.2M+6.0%$10.1M+2.8%$10.3M+392.7%$10.1M+1611.2%$9.6M$9.8M+647.7%
Income Tax$29.8M+36.8%$76.8M+53.9%$39.0M+2.9%$21.8M-3.9%$49.9M-8.9%$25.8M-33.6%$37.9M$22.6M-48.6%
Net Income$97.7M+34.1%$250.6M+52.9%$129.8M+4.2%$72.8M-2.2%$163.8M-9.0%$230.6M-15.2%$124.6M$74.5M-52.1%
EPS (Basic)$6.25+34.1%$16.04+54.4%$8.31+7.5%$4.66+1.5%$10.39-6.3%$13.40-12.7%$7.73$4.59-51.6%
EPS (Diluted)$6.25+34.1%$16.04+54.4%$8.31+7.5%$4.66+1.5%$10.39-6.3%$13.40-12.7%$7.73$4.59-51.6%
Diluted Shares (Avg)16M0.0%16M-1.0%16M-3.1%16M-3.8%16M-2.8%N/A16M16M-0.9%

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA.

DDS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DDS quarterly balance sheet
MetricQ3'2710-QQ2'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-KQ4'2510-KQ3'2510-Q
Total Assets$3.7B+1.8%$4.1B+5.9%$4.3B+4.0%$3.7B+0.6%$3.9B-0.8%$3.5B+2.4%$4.1B$3.7B-6.1%
Current Assets$2.7B+4.2%$3.0B+10.1%$3.2B+7.7%$2.6B+4.8%$2.8B+2.2%$2.4B+7.2%$2.9B$2.5B-8.0%
Cash & Equivalents$763.1M-24.6%$1.2B+28.6%$1.1B+17.2%$1.0B+6.9%$900.5M+10.1%$717.9M-11.2%$980.4M$946.7M+12.4%
Short-Term Investments$0$0$0$0$0$0$0$0
Accounts Receivable$45.4M-13.0%$47.1M-17.4%$44.9M-27.3%$52.2M-19.0%$56.9M+15.6%$55.7M-8.0%$61.7M$64.5M+12.3%
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$1.6B-7.7%$2.1B+3.1%$2.3B+3.8%$1.8B+3.1%$2.0B-0.6%$1.7B-1.0%$2.2B$1.7B-17.8%
Current Liabilities$883.8M-7.8%$1.3B+12.3%$1.4B+16.9%$958.7M+22.9%$1.1B+1.5%$834.9M+0.9%$1.2B$780.3M-35.1%
Non-Current Liabilities$745.4M-7.6%$824.9M-8.6%$807.6M-13.4%$806.6M-13.5%$902.4M-3.2%$900.0M-2.6%$932.9M$932.6M+5.7%
Total Equity$2.1B+10.5%$2.0B+9.0%$2.0B+4.2%$1.9B-1.5%$1.9B-0.9%$1.8B+5.8%$2.0B$1.9B+7.5%
Retained Earnings$6.7B+3.0%$6.6B+2.7%$6.6B+2.6%$6.5B+2.6%$6.4B+2.6%$6.2B+3.0%$6.4B$6.3B+2.7%

Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.

DDS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DDS quarterly cash flow statement
MetricQ3'2710-QQ2'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-KQ4'2510-KQ3'2510-Q
Operating Cash Flow-$37.2M-142.9%$364.0M+56.5%$186.5M+7.5%$86.8M+226.8%$232.6M-4.8%$364.7M-16.4%$173.5M-$68.4M-238.9%
Depreciation & Amortization$44.4M-0.7%$43.3M-2.7%$44.4M+0.7%$44.7M-3.7%$44.5M-3.5%$41.3M-6.7%$44.0M$46.4M+3.7%
Capital Expenditures$22.3M-16.5%$17.2M+2.1%$30.3M+8.0%$26.7M+2.9%$16.9M-52.1%$15.4M-45.5%$28.1M$25.9M-36.6%
Free Cash Flow-$59.5M-198.9%$346.8M+60.7%$156.2M+7.4%$60.1M+163.7%$215.8M+3.1%$349.3M-14.4%$145.4M-$94.3M-1225.0%
Investing Cash Flow-$256.7M-767.4%-$63.1M-214.1%-$45.4M-47.5%$38.5M-80.9%$55.3M+124.0%-$209.6M-69.7%-$30.8M$201.4M+197.5%
Financing Cash Flow-$100.7M-633.7%-$4.7M+95.6%-$3.9M+96.4%-$13.7M-238.2%-$105.3M-2495.2%-$417.7M-20.5%-$109.1M-$4.1M+91.8%
Dividends Paid$4.7M+19.4%$4.7M+17.8%$3.9M-3.8%$3.9M-3.3%$4.0M-2.0%$401.6M+22.3%$4.1M$4.1M+23.5%
Share BuybacksN/AN/A$0$9.8M$98.0M$16.0M-11.7%N/AN/A

Not reported in any period shown, so not listed: Stock-Based Compensation.

DDS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DDS quarterly financial ratios
MetricQ3'2710-QQ2'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-KQ4'2510-KQ3'2510-Q
Gross Margin39.1%+3.0pp43.9%+0.6pp42.7%+0.9pp36.1%-0.9pp43.4%-0.6pp34.9%-0.6pp41.9%37.0%-5.7pp
Net Margin6.4%+1.6pp15.8%+5.2pp8.7%+0.1pp4.7%-0.2pp10.6%-0.9pp11.1%-1.3pp8.6%4.9%-5.4pp
Return on Equity4.6%+0.8pp12.4%+3.6pp6.3%0.0pp3.8%0.0pp8.8%-0.8pp12.8%-3.2pp6.3%3.8%-4.8pp
Return on Assets2.6%+0.6pp6.1%+1.9pp3.0%0.0pp2.0%0.0pp4.2%-0.4pp6.5%-1.4pp3.0%2.0%-2.0pp
Current Ratio3.03+0.4x2.370.0x2.19-0.2x2.68-0.5x2.410.0x2.84+0.2x2.383.14+0.9x
Debt-to-Equity0.77-0.2x1.04-0.1x1.100.0x0.920.0x1.100.0x0.97-0.1x1.110.88-0.3x
Asset Turnover0.410.0x0.380.0x0.350.0x0.420.0x0.400.0x0.590.0x0.350.410.0x
FCF Margin-3.9%-7.8pp21.8%+7.9pp10.5%+0.5pp3.9%+10.1pp14.0%+0.7pp16.8%-1.7pp10.0%-6.2%-6.8pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Dillard's, Inc. DDS FY2025 $6.6B $570.2M 8.7% $10.4B —
Macy's Inc. M FY2025 $22.6B $642.0M 2.8% $6.3B 44/100
Kohls Corporation KSS FY2025 $15.5B $272.0M 1.8% $2.4B 41/100
The Gap, Inc. GAP FY2025 $15.4B $816.0M 5.3% $8.1B 58/100
Floor & Decor Holdings, Inc. FND FY2025 $4.7B $208.6M 4.5% $4.8B 54/100
CarMax Inc. KMX FY2026 $25.9B $247.0M 0.9% $7.6B 25/100

Frequently Asked Questions

What is Dillard's, Inc.'s annual revenue?

Dillard's, Inc. (DDS) reported $6.6B in total revenue for fiscal year 2025. This represents a -0.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Dillard's, Inc.'s revenue growing?

Dillard's, Inc. (DDS) revenue declined by 0.4% year-over-year, from $6.6B to $6.6B in fiscal year 2025.

Is Dillard's, Inc. profitable?

Yes, Dillard's, Inc. (DDS) reported a net income of $570.2M in fiscal year 2025, with a net profit margin of 8.7%.

Dillard's, Inc. (DDS) reported diluted earnings per share of $36.42 for fiscal year 2025. This represents a -1.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Dillard's, Inc. (DDS) had a gross margin of 39.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Dillard's, Inc. (DDS) had a net profit margin of 8.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Dillard's, Inc. (DDS) paid $31.10 per share in dividends during fiscal year 2025.

Dillard's, Inc. (DDS) has a return on equity of 32.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Dillard's, Inc. (DDS) generated $623.6M in free cash flow during fiscal year 2025. This represents a 2.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Dillard's, Inc. (DDS) generated $717.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Dillard's, Inc. (DDS) had $3.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Dillard's, Inc. (DDS) invested $93.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Dillard's, Inc. (DDS) spent $107.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Dillard's, Inc. (DDS) had a current ratio of 2.65 as of fiscal year 2025, which is generally considered healthy.

Dillard's, Inc. (DDS) had a debt-to-equity ratio of 0.97 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Dillard's, Inc. (DDS) had a return on assets of 16.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Dillard's, Inc. (DDS) trades at 18.2x earnings, its market capitalization divided by net income of $570.2M net income, FY2025. The market capitalization is $10.4B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Dillard's, Inc. (DDS) trades at 1.6x sales, its market capitalization divided by revenue of $6.6B revenue, FY2025. The market capitalization is $10.4B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Dillard's, Inc. (DDS) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Dillard's, Inc. (DDS) has an earnings quality ratio of 1.26x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top